Targets and strategies for the antiviral chemotherapy of AIDS
- 31 May 1990
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 11 (5) , 198-205
- https://doi.org/10.1016/0165-6147(90)90115-o
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- A Synthetic HIV-1 Protease Inhibitor with Antiviral Activity Arrests HIV-Like Particle MaturationScience, 1990
- Novel sulfated polymers as highly potent and selective inhibitors of human immunodeficiency virus replication and giant cell formationAntimicrobial Agents and Chemotherapy, 1990
- Syncytium Formation and Destruction of Bystander CD4+ Cells Cocultured with T Cells Persistently Infected with Human Immunodeficiency Virus as Demonstrated by Flow CytometryJournal of General Virology, 1989
- Oral Dextran Sulfate (UAOO1) in the Treatment of the Acquired Immunodeficiency Syndrome (AIDS) and AIDS-Related ComplexAnnals of Internal Medicine, 1989
- Designing CD4 immunoadhesins for AIDS therapyNature, 1989
- The structure of antiviral agents that inhibit uncoating when complexed with viral capsidesAntiviral Research, 1989
- Phosphonylmethoxyethyl purine derivatives, a new class of anti-human immunodeficiency virus agentsAntimicrobial Agents and Chemotherapy, 1988
- Dextran Sulfate Suppression of Viruses in the HIV Family: Inhibition of Virion Binding to CD4 + CellsScience, 1988
- Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoproteinNature, 1986
- Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicityNature, 1986